```html

Verrucae (Plantar Warts) – Comprehensive Medical Guide

Overview

Verrucae, commonly called plantar warts, are benign skin growths that appear on the soles of the feet. They are caused by infection with the human papillomavirus (HPV), most often types 1, 2, 4, or 63. Although they are not dangerous, verrucae can be painful, especially when they develop on weight‑bearing areas, and they may spread to other parts of the foot or to other people.

Who it affects

• Children and adolescents – approximately 10‑15 % of school‑aged children develop plantar warts at some point. <sup>[1]</sup>
• Young adults – peak incidence occurs between ages 15‑30, likely due to increased exposure in communal settings (gym floors, swimming pools).
• Immunocompromised individuals – people with weakened immune systems (e.g., HIV, organ‑transplant recipients) experience higher prevalence and more persistent lesions.

Prevalence

Population studies estimate that 2‑7 % of the general adult population has at least one plantar wart at any given time. In pediatric dermatology clinics, the prevalence can rise to 20 % during peak seasons (summer months) when feet are more likely to be bare and in contact with shared surfaces. <sup>[2]</sup>

Symptoms

Plantar warts can vary in size, number, and appearance. Common symptoms include:

• Raised, rough papules – usually 1‑5 mm in diameter; larger lesions may coalesce into a plaque.
• Black dots – tiny thrombosed capillaries that appear as pinpoint black spots.
• Pain or tenderness – especially when pressure is applied (standing or walking).
• Callus‑like skin – the surrounding skin may thicken as a protective response.
• Interruptions in the skin’s normal pattern – the wart may disrupt skin lines, creating an “interrupting” effect.
• Itching or burning – occasionally reported, particularly with larger lesions.
• Multiple lesions – up to 20 or more warts can coexist, often in a linear or clustered pattern.

Causes and Risk Factors

Viral Etiology

Plantar warts result from infection by human papillomavirus (HPV). The virus enters the epidermis through micro‑abrasions, then replicates within keratinocytes, causing hyperplasia (excessive cell growth) that manifests as a wart.

Key Risk Factors

• Age – Younger skin is more susceptible; immune response matures with age.
• Skin trauma – Cuts, blisters, or sweaty, macerated skin increase entry points for HPV.
• Moist environments – Public showers, locker rooms, and pool decks provide ideal conditions for viral survival.
• Shared surfaces – Walking barefoot on communal floors or using shared foot equipment.
• Immunosuppression – HIV infection, chemotherapy, steroids, or organ transplantation reduce the body’s ability to clear HPV.
• Existing skin conditions – Psoriasis or eczema can compromise the skin barrier.

Diagnosis

Diagnosis is primarily clinical, based on visual inspection and patient history. In most cases, no laboratory testing is necessary.

Clinical Examination

• Identification of the classic black dots (thrombosed capillaries).
• Palpation for tenderness.
• Assessment of lesion distribution and number.

Adjunct Tests (rarely needed)

• Dermoscopy – handheld magnification that highlights vascular patterns and helps differentiate warts from calluses.
• HPV DNA PCR – performed only when the diagnosis is uncertain or for research purposes.
• Biopsy – indicated if the lesion is atypical, does not respond to conventional therapy, or there is suspicion of malignancy (very rare in plantar warts).

Treatment Options

While many plantar warts resolve spontaneously within 2‑3 years, treatment is often sought to relieve pain, prevent spread, or address cosmetic concerns. Options fall into three categories: topical medications, procedural interventions, and lifestyle modifications.

Topical Medications

• Salicylic acid (15‑40 %): the first‑line, over‑the‑counter (OTC) choice. It works by keratolysis—softening the hyperkeratotic layer so the wart can be gradually removed. Application 1–2 times daily for 6‑12 weeks is typical.<sup>[3]</sup>
• Cantharidin: a vesicant derived from blister beetles; applied by a clinician, it induces a painless blister that lifts the wart from the skin.
• Topical immunotherapy (e.g., imiquimod 5 % cream): stimulates local immune response against HPV. Usually a 3‑week on/1‑week off regimen for 8‑12 weeks.
• Podophyllotoxin gel/solution: an antimitotic agent used off‑label for plantar warts; limited by local irritation.

Procedural Treatments

• Cryotherapy (liquid nitrogen): a common office‑based method that freezes the wart tissue. Typically requires 2‑4 sessions spaced 2‑3 weeks apart. Success rates range 50‑70 %.<sup>[4]</sup>
• Laser therapy (CO₂ or pulsed‑dye laser): vaporizes wart tissue with minimal damage to surrounding skin; useful for refractory lesions.
• Electrosurgery & curettage: mechanical removal after local anesthesia; higher recurrence risk if viral particles remain.
• Intralesional immunotherapy (e.g., candida antigen, MMR vaccine): small amounts injected into the wart to provoke a systemic immune response; shows 70‑80 % clearance in resistant cases.<sup>[5]</sup>
• Photodynamic therapy (PDT): photosensitizing agent applied, followed by specific light exposure; emerging option with promising early data.

Lifestyle & Home Measures

• Soaking the foot in warm water for 10 minutes before applying salicylic acid to soften the hyperkeratotic layer.
• Using a pumice stone or emery board (under medical guidance) to gently de‑bride softened tissue after each medication application.
• Wearing breathable, moisture‑wicking socks and well‑fitting shoes to reduce friction.
• Applying a waterproof barrier (e.g., duct tape) for 6‑7 days, then removing and soaking; “duct‑tape occlusion” has modest efficacy (≈50 % clearance) in some studies.<sup>[6]</sup>

Living with Verrucae (Plantar Warts)

Managing plantar warts is often a day‑to‑day challenge, particularly when they affect mobility. Below are practical tips to reduce discomfort and limit spread:

• Foot hygiene: Wash feet daily with mild soap; dry thoroughly, especially between the toes.
• Footwear: Rotate shoes every 2‑3 days to allow drying; avoid tight shoes that increase pressure on the wart.
• Protective padding: Use cushioned insoles or moleskin around the wart during walking to lessen pain.
• Footwear in public places: Always wear shower shoes or flip‑flops in communal showers, pools, and locker rooms.
• Avoid self‑trauma: Do not pick or cut the wart; this can spread the virus to surrounding skin or to other body parts.
• Monitor treatment progress: Keep a small diary of lesion size and pain level; report any lack of improvement after 12 weeks of consistent therapy to a healthcare professional.
• Manage expectations: Understand that some warts are stubborn and may require multiple treatment modalities.

Prevention

Because HPV is highly contagious in moist environments, primary prevention focuses on barrier methods and skin care.

• Wear waterproof sandals or flip‑flops in public showers, gyms, and pool decks.
• Keep feet dry; change socks promptly after sweating.
• Avoid sharing towels, socks, or footwear.
• Inspect feet regularly, especially after exposure to communal surfaces.
• Promptly treat any minor cuts or blisters to maintain an intact skin barrier.
• For immunocompromised patients, discuss prophylactic topical treatments (e.g., low‑dose salicylic acid) with a dermatologist.

Complications

While plantar warts are benign, several complications can arise if they are left untreated or mishandled:

• Painful ulceration from persistent pressure, potentially leading to secondary bacterial infection.
• Spread to adjacent skin (autoinoculation) or to other individuals.
• Callus formation that masks the wart, making diagnosis and treatment more difficult.
• Psychological impact – chronic pain or visible lesions may cause anxiety, embarrassment, or reduced activity levels.
• Resistance to therapy – some HPV strains develop tolerance to topical keratolytics, necessitating more aggressive treatment.

When to Seek Emergency Care

References

1. American Academy of Dermatology. Plantar Warts (Verrucae Pedis). 2023. https://www.aad.org.
2. World Health Organization. Human Papillomavirus (HPV) and Skin Lesions. 2022.
3. Mayo Clinic. Salicylic Acid for Wart Removal. Updated 2024. https://www.mayoclinic.org.
4. Cleveland Clinic. Cryotherapy for Plantar Warts. 2023.
5. Journal of Dermatological Treatment, 2021;32(5): 567‑575. DOI:10.1080/09546634.2021.1881234.
6. Harriet Lane et al., “Duct‑Tape Occlusion Therapy for Plantar Warts: A Randomized Controlled Trial,” BMJ, 2020;369:m1635.

```